Latest Derivatives News

Rimfire Pacific Mining confirms Currajong as a standout scandium prospect with strong drill results and secures $3.5 million in fresh equity to advance exploration and working capital. The company also strikes a $700K option deal for its Cowal Copper Gold Project amid ongoing legal challenges.

Peak Minerals reports a significant expansion of heavy mineralisation at its Minta Rutile Project in Cameroon, alongside a $3.5 million strategic investment that fully funds its 2025 exploration plans.

Noxopharm has initiated its HERACLES clinical trial for SOF-SKN, marking a key milestone for its Sofra platform, while deepening partnerships and actively seeking new funding to sustain development.

Australian Rare Earths Limited (ASX, AR3) reports successful metallurgical testwork at its Koppamurra Rare Earths Project, producing 34kg of Mixed Rare Earth Oxide from heap leach solutions, paving the way for streamlined, cost-effective rare earth processing.

Mach7 Technologies closes FY25 with solid recurring revenue growth, positive cash flow, and a refreshed leadership team focused on innovation and customer value.

Stellar Resources advances exploration at its East Renison Project near Tasmania’s Renison Tin Mine, backed by a $55,000 government drilling grant targeting high-grade polymetallic zones.

Victory Metals has produced a 94% total rare earth oxide product enriched in heavy rare earths from its North Stanmore project, marking a first for Australian clay-hosted deposits and setting a new industry benchmark.

Diablo Resources advances exploration at its Phoenix Copper Project with significant rock sampling results and drill permits granted for key prospects, setting the stage for drilling in Q3 2025.

Tivan Limited has taken significant strides in financing its Speewah Fluorite Project, securing a conditional Letter of Support from Export Finance Australia and moving into the Northern Australia Infrastructure Facility’s due diligence phase. These developments mark important progress toward full project funding and highlight fluorite’s rising strategic importance.

Chilwa Minerals reports encouraging metallurgical testwork from its Mposa Deposit, confirming the potential for commercial-grade ilmenite and promising by-products including zircon and rare earth minerals. These findings will shape the upcoming Scoping Study and flowsheet design.

Neurizon Therapeutics has formally responded to the FDA's clinical hold on its lead ALS drug NUZ-001, submitting new animal safety data. The company aims to join the HEALEY ALS Platform Trial by late 2025, pending regulatory approval.

Waypoint REIT’s half-year update reveals a 3.4% portfolio valuation increase to $2.89 billion, alongside a strategic pause in its $50 million buyback program after $32.9 million in purchases.